Devices › Catheter, intravascular occluding, temporary
Device brand name · Carotid shunt
Pruitt F3 Carotid Shunt: medical device reports filed with FDA
395 reports name it, 2017–2026. Manufacturer given most often on reports: Lemaitre Vascular. Product code MJN.
- 395
- device reports naming the brand
- 0% of all MAUDE reports · about 42 a year
- 73
- reports, 12 months to August 2026
- 67 in the 12 months before
- 92.9%
- classified as malfunction
- 75.4% across the product code
- 0.3%
- classified as death, as reported
- 1 reports · not verified by FDA
FDA's MAUDE database holds 395 reports that name the brand "Pruitt F3 Carotid Shunt" (carotid shunt), received between January 2017 and August 2026; the manufacturer given most often on reports is Lemaitre Vascular. Spellings of one product vary from report to report.
73 reports arrived in the 12 months to August 2026, close to the 67 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (92.9%), injury (6.8%) and death (0.3%); across all catheter, intravascular occluding, temporary reports (product code MJN) death is recorded in 4.3% and malfunction in 75.4%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are inflation problem (22.3%), leak/splash (16.5%) and material rupture (14.7%). The patient problems coded most often are no patient involvement, hemorrhage/blood loss/bleeding and blood loss. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 2,348 reports carrying product code MJN. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Inflation problem | 88 | 22.3% | 9.7% |
| Leak/splashthe device leaked | 65 | 16.5% | 10.9% |
| Material rupture | 58 | 14.7% | 15.6% |
| Fluid/blood leak | 55 | 13.9% | 5.3% |
| Failure to deflate | 32 | 8.1% | 2.3% |
| Material puncture/hole | 30 | 7.6% | 2.9% |
| Material deformation | 15 | 3.8% | 1.3% |
| Deflation problem | 10 | 2.5% | 13.9% |
| Thickening of material | 8 | 2% | 0.3% |
| Flaked | 5 | 1.3% | 0.5% |
| Obstruction of flow | 5 | 1.3% | 0.2% |
| Material integrity problema problem with the device material | 4 | 1% | 0.2% |
| Unintended deflation | 4 | 1% | 0.2% |
| Material perforation | 3 | 0.8% | 0.2% |
| Mechanical problema mechanical problem | 3 | 0.8% | 0.3% |
| Unintended movement | 3 | 0.8% | 0.1% |
| Degraded | 2 | 0.5% | 0% |
| Device contaminated during manufacture or shipping | 2 | 0.5% | 0.1% |
| Device dislodged or dislocated | 2 | 0.5% | 0.1% |
| Positioning failure | 2 | 0.5% | 0.5% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 11 | 2.8% |
| Hemorrhage/blood loss/bleeding | 8 | 2% |
| Blood loss | 2 | 0.5% |
| Hemorrhagic stroke | 2 | 0.5% |
| Intraoperative cardiac valve injury | 1 | 0.3% |
| Ischemia | 1 | 0.3% |
| Ischemia stroke | 1 | 0.3% |
| Perforation of vessels | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Pruitt F3 Carotid Shunt | Product code MJN | All MAUDE reports |
|---|---|---|---|
| Reports | 395 | 2,348 | 26,136,888 |
| Share of that pool | — | 16.8% | 0% |
| Classified as death, per 1,000 reports | 3 | 43 | 9 |
| Classified as injury | 6.8% | 19.5% | 36.2% |
| Classified as malfunction | 92.9% | 75.4% | 62.3% |
| Filed by the manufacturer | 98.5% | 96.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MJN
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Micrus Microcoil System | 167 | 0 | 5.4% |
| GORE Molding & Occlusion Balloon Catheter | 165 | 30 | 5.5% |
| Equalizer | 215 | 2 | 0% |
| Balloon | 330 | 48 | 0.3% |
| TufTex Over-the-Wire Embolectomy Catheter | 361 | 159 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Pruitt F3 Carotid Shunt reports
How many FDA reports name Pruitt F3 Carotid Shunt?
395 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 73 in the latest 12 months.
What kinds of events are reported?
malfunction (92.9%), injury (6.8%) and death (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
inflation problem (22.3%), leak/splash (16.5%), material rupture (14.7%), fluid/blood leak (13.9%) and failure to deflate (8.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (98.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Pruitt F3 Carotid Shunt was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.